Compare AbCellera Biologics Inc (ABCL) vs Gold Fields Limited (GFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Gold Fields Limited — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Gold Fields Limited trades at $42 (market cap $36.07B). The key difference: Gold Fields Limited is far larger — about 12.1× AbCellera Biologics Inc's market cap, and Gold Fields Limited pays a 5.76% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | GFI | |
|---|---|---|
Market Cap | $2.99B | $36.07B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $61.52 |
52-Week Low | $2.78 | $29.31 |
Enterprise Value | $2.58B | $37.51B |
Dividend Yield | — | 5.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →
